EFOSA AIRUEHIA: Open Payments
NPI 1972767986 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,711 in 88 payments from 16 companies in 2025. Trend: 2023 $1,826 · 2024 $1,731 · 2025 $1,711
Food & beverage: $1,711
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 13 | $418 |
| ABBVIE INC. | 30 | $375 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $225 |
| Corium, LLC | 6 | $157 |
| Vanda Pharmaceuticals Inc. | 3 | $79 |
| Axsome Therapeutics, Inc. | 3 | $76 |
| Collegium Pharmaceutical, Inc. | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $52 |
| Neurocrine BioSciences, Inc. | 2 | $44 |
Products named: SPRAVATO, VRAYLAR, CAPLYTA, Azstarys, REXULTI, FANAPT, Auvelity, Jornay PM.
Industry payments across TX — which companies pay providers there.
